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Department of Pathology, Institute of Tropical Medicine, Nagasaki University
We have planned the COE international symposium entitled "present situation and fu-
fare prospects of tropical medicine in developing world" on the occasion of COE (Center of
Excellence) appointment of our institute. This symposium was organized by our Research
Institute of Tropical Medicine, Nagasaki University (Government) as authorized by Ministry
of Education, Science, C山ture, and Sports. COE programs supporting core research institu-
tions are ongoing by the Government, and our institute has been appointed to be one of them
performing excellent work.
During the past decade international relationships have been strained by a variety of
problems not only diplomatic and economic but also ethnical and religious. The international
situation presents a lot of complex and difficult problems which are changing rapidly. The
field of tropical medicine is no exception. There are overwhelming and vitally important
health problems in tropical areas located for the most part in developing countries. For the
purpose of seeking suitable guideline policies for the 21 century, it is exceedingly timely to
review activities of the relevant institutions in tropical countries.
In 1992, the symposium entitled ``present situation and future prospects of tropical medi-
cine in (so-called economically) advanced countries" (Inst. Trop. Med. Nagasaki Univ., 1992) was
held as part of the activities to celebrate the 50th anniversary of Institute of Tropical
Medicine, Nagasaki University. After that, same kind of meeting for developing countries has
been expected as second phase.
I have suggested at the symposium in 1992 a few topics in the introductory remarks for
discussion concerning institutions of tropical medicine as shown below:
-The Principal function of the institution should be organizing of research system and
sponsorship for research activities. Additional functions include the dissemination and ex-
change of information, the promotion of collaborative work and other appropriate scientific
activities.
-The Organization and infrastructure may differ from institute to institute depending
upon respective circumstances.
-As for Research activities, the expanded definition of tropical medicine and recent
scientific advances in the field have resulted in a broadening of basic scientific policies and
research programs, and resulted in a demand for the participation of molecular biology and
modern laboratory techniques. Attention must also be paid to the enhancement of field-work
and primary health care activities.
-The annual Budget for the management of our institute is provided by the govern-
ment and administered by a treasurer. Research funding is another important matter. Each
168
research scientist or group should have the opportunity to receive research funding from
every area of society both public and private.
-Laboratory facilities including special ones for tropical medicine should be available on
the basis of the budget and research funding.
- collaboration with other organizations is inevitable.
-Education, teaching program, and training system are important. Our educational pro-
gram is designed so that each academic department is responsible for its own academic field
of expertise. They are: 1) lectures and practices for under-graduate medical students, 2) a
four-year postgraduate course leading to Ph. D., 3) a three-month training course in tropical
medicine for doctors, nurses, technologists and relevant professionals, and 4) the medical
research training course for researchers from abroad supported by Japan International
Cooperation Agency QICA).
-In addition to the programs mentioned above, our routine Academic services include
laboratory diagnostic examination of viral, bacterial and parasitic diseases, postmortem ex-
aminations and histological diagnostic pathology, and the clinical treatment of patients with
infectious diseases at the University Hospital.
-I would like our guest speakers to describe the Future prospects of their institutions.
one of the responsibilities of the institution of tropical medicine should be to provide
leadership and direction in the advancement of tropical medicine and primary health care, and
to perform other appropriate duties as required.耶th regard to our strategy for the de-
velopment of modern tropical medicine, it is important to; 1) encourage the formation of in-
ternational cooperation programs, 2) distribute information about opportunities for education
and training, and 3) give advice to relevant government organizations based upon our
knowledge and experience.
In his presidential address, Krokstad (1993) have mentioned what perspectives sho山d
be brought to bear on tropical medicine and hygiene by a society whose members are
primarily from developed countries such as the United States and Canada. The field demands
an understanding of both the developing and developed worlds. The task before people as
members concerned with tropical medicine is to relate the needs and opportunities of the
developing world to the human and technical resources of the developed world｡
The Hot Zone (Preston, 1994) tells the dramatic story in depth for the first time, giving
an absolutely hair-raising account of the appearance of rare and lethal viruses and their
･cashes" into the human race. As the tropical wildernesses of the -rid are destroyed,
previously unknown viruses that have lived undetected in the rain forest for eons are entering
human populations. The appearance of AIDS is part of the pattern, and the implications for
the future of the human species are terrifying. So far ordinary research are being performed
in developed countries, it is important characteristic research should be done in the tropics.
Let me show you some examples of combination of work on the tropical field and basic
medicine in the laboratory. Nasopharyngeal carinoma is an epithelial tumor with a distinct
geographic distribution and characteristic histologic appearance. It is rare in Europe and
North America, but it is among the most common cancers in southern China and Southeast
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Asia. Genetic predisposition, environmental factors, and Epstein-Barr virus (EBV) have been
associated with the pathogenesis of this tumor. The predisposing genetic and environmental
factors in the pathogenesis of this tumor with particular emphasis on the role of EBV have
been discussed (Zhong et al., 1993; Senba et al., 1994a; Senba et al, 1994b; Vaughan et al,
1996; Vasef et al., 1997)I The pathogenesis of Hodgkin's disease (HD) is suggested to have a
strong association with EBV. However, HD related to EBV shows a wide geographic varia-
tion in epidemiology. Because these variations among different populations suggest an inter-
action of environmental factors and a direct role of EBV infection, a comparative study on
histologic and virologic features of the disease in western Kenya and Nagasaki, Japan has
been performed (Kusuda et al., 1998). The age distribution of HD showed two peaks in
younger population and older population in western Kenya, and a peak in older population
with low peak in middle-aged group in Nagasaki, Japan. The most common subtype of HD in
both countries was mixed cellularity, followed by nodular sclerosis, lymphocyte depletion, and
lymphocyte predominance. Mixed cellularity showed a significantly high prevalence among
Kenyan younger children. Using in situ hybridization method, EBV-encoded RNA (EBER-1)
was detected in 79% of the Kenyan cases and 59% of the Japanese cases. Mixed cellularity
showed a strong correlation with EBER-1 in both countries. These results sugggest that EBV
plays a strong role in the pathogenesis of HD among young children in both countries. En-
vironmental and genetic factors may have a role in addition to EBV in the pathogenesis of
HD. A sudden increase in the number of Kaposi's sarcoma has been observed along with the
epidemic of AIDS. The epidemiology and geographical pathology of Kaposi's sarcoma are
quite characteristic.
Institute of Tropical Medicine, Nagasaki University is the only government collabora-
tion research center in the field of tropical medicine in Japan. During the sixty years since its
inauguration, our institute has devoted itself to research and education in the field of endemic
and tropical medicine and the exchange of scientific and technological knowledge through
medical cooperation, both within this coutry and abroad.
Historically, Nagasaki was Japan's only gateway for European culture from the 17th to
the 19th century and served as the cradle for Western舎nedicine, especially by Dutch, Ger-
man, and British people. The city is blessed with natural beauty and a unique cultural
heritage handed down over the past 200 years.
On the basis of our commitment to tropical medicine and to international friendship, we
intend to continue our collaborations with developing and advanced countries. I hope that the
present symposium will be the first of many future events presented by speakers from
tropical world. You will be able to have fruitful results, and get new ideas, new information
and new approaches in torpical medicine with special emphasis on challenges for the future.
we look forward to your continuing recognition and friendship, and welcome any proposals
you have for collaboration programs in the future.
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